Aesthetic Applications of Radiofrequency: Lymphatic and Perfusion Assessment.
Journal
Plastic and reconstructive surgery. Global open
ISSN: 2169-7574
Titre abrégé: Plast Reconstr Surg Glob Open
Pays: United States
ID NLM: 101622231
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
19
02
2020
accepted:
18
08
2020
entrez:
11
11
2020
pubmed:
12
11
2020
medline:
12
11
2020
Statut:
epublish
Résumé
The use of radiofrequency in aesthetics has increased in popularity since the early 2000s. To date, there have been limited studies investigating the effect of thermal energy secondary to radiofrequency treatment. The purpose of this study was to evaluate perfusion and lymphatic assessment tools pre and post bipolar and fractional radiofrequency treatment. A retrospective IRB-approved study was conducted between January 2019 and April 2019. Patients who were independently deemed appropriate candidates for radiofrequency soft tissue remodeling were evaluated. Diagnostic perfusion and lymphatic imaging obtained were reviewed using indocyanine green (SPY, Stryker) and optical coherence tomography (Vivosight OCT). A total of 63 patients were treated during the study period, of which 37 had diagnostic perfusion and lymphatic imaging. Average patient age was 47 (STD 12), 95% (35/37) of patients were women, and no patients were active smokers. In total, 27% (10/37) of patients were post-surgical patients with recurrent laxity, 32% (12/37) did not have enough skin laxity to justify traditional excisions procedures, and 41% (15/37) may have been candidates for excisional procedures but were willing to accept more moderate results to avoid excisions surgery. Indocyanine green perfusion and lymphatic assessment for bipolar and fractional radiofrequency, as well as optical coherence tomography pre and post radiofrequency, did not show compromise from thermal injury. This study supports safety of radiofrequency in terms of preservation of tissue perfusion and lymphatic drainage. This correlated to our low clinical incidence of burns, prolonged swelling, or tissue ischemia.
Sections du résumé
BACKGROUND
BACKGROUND
The use of radiofrequency in aesthetics has increased in popularity since the early 2000s. To date, there have been limited studies investigating the effect of thermal energy secondary to radiofrequency treatment. The purpose of this study was to evaluate perfusion and lymphatic assessment tools pre and post bipolar and fractional radiofrequency treatment.
METHODS
METHODS
A retrospective IRB-approved study was conducted between January 2019 and April 2019. Patients who were independently deemed appropriate candidates for radiofrequency soft tissue remodeling were evaluated. Diagnostic perfusion and lymphatic imaging obtained were reviewed using indocyanine green (SPY, Stryker) and optical coherence tomography (Vivosight OCT).
RESULTS
RESULTS
A total of 63 patients were treated during the study period, of which 37 had diagnostic perfusion and lymphatic imaging. Average patient age was 47 (STD 12), 95% (35/37) of patients were women, and no patients were active smokers. In total, 27% (10/37) of patients were post-surgical patients with recurrent laxity, 32% (12/37) did not have enough skin laxity to justify traditional excisions procedures, and 41% (15/37) may have been candidates for excisional procedures but were willing to accept more moderate results to avoid excisions surgery. Indocyanine green perfusion and lymphatic assessment for bipolar and fractional radiofrequency, as well as optical coherence tomography pre and post radiofrequency, did not show compromise from thermal injury.
CONCLUSIONS
CONCLUSIONS
This study supports safety of radiofrequency in terms of preservation of tissue perfusion and lymphatic drainage. This correlated to our low clinical incidence of burns, prolonged swelling, or tissue ischemia.
Identifiants
pubmed: 33173697
doi: 10.1097/GOX.0000000000003193
pmc: PMC7647541
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e3193Informations de copyright
Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.
Déclaration de conflit d'intérêts
Disclosure: Erez Dayan, MD: Consultant/Investigator, InMode; Book Royalties, Thieme, Elsevier. Spero Theodorou, MD: Consultant, InMode; Book Royalties, Thieme. Rod Rohrich, MD: Micrins instrument royalties; Thieme, book royalties; Investigator, MTF, Galderma, Allergan, InMode. A. Jay Burns, MD: Consultant, Hint MD, Investigator/Consultant, Sciton, Allergan, InMode.
Références
Clin Exp Dermatol. 2007 Jan;32(1):135-7
pubmed: 17163958
Aesthetic Plast Surg. 2009 May;33(3):283-94
pubmed: 19437070
Lasers Surg Med. 2005 Dec;37(5):343-9
pubmed: 16365887
J Reconstr Microsurg. 2016 Jan;32(1):72-9
pubmed: 26422172
Lasers Med Sci. 2001;16(4):291-8
pubmed: 11702635
Arch Facial Plast Surg. 2004 Nov-Dec;6(6):370-3
pubmed: 15545529
J Invest Surg. 2019 Jul 23;:1-8
pubmed: 31335230
Clin Plast Surg. 2016 Jul;43(3):551-6
pubmed: 27363769
J Res Med Sci. 2011 Nov;16(11):1448-51
pubmed: 22973346
J Cosmet Dermatol. 2018 Jun;17(3):361-364
pubmed: 29524305
Dermatol Surg. 2007 Mar;33(3):300-9
pubmed: 17338687
Aesthet Surg J. 2005 Nov-Dec;25(6):638-42
pubmed: 19338872
Dermatol Surg. 2007 May;33(5):543-51
pubmed: 17451576
Dermatol Surg. 2003 Apr;29(4):333-9; discussion 339
pubmed: 12656809
Lasers Surg Med. 2006 Jul;38(6):575-9
pubmed: 16850498
Clin Plast Surg. 2016 Jul;43(3):557-65
pubmed: 27363770
Facial Plast Surg Clin North Am. 2007 May;15(2):169-77, v
pubmed: 17544932
Facial Plast Surg. 2005 Feb;21(1):65-73
pubmed: 15988658
J Drugs Dermatol. 2006 Sep;5(8):714-22
pubmed: 16989185
Clin Plast Surg. 2016 Jul;43(3):567-75
pubmed: 27363771
Facial Plast Surg. 2014 Feb;30(1):62-7
pubmed: 24488639
J Reconstr Microsurg. 2019 Feb;35(2):138-144
pubmed: 30099734
Arch Dermatol. 2004 Feb;140(2):204-9
pubmed: 14967794
Ann Surg Oncol. 2020 Feb;27(2):399-406
pubmed: 31468214
Lymphat Res Biol. 2019 Jun;17(3):329-333
pubmed: 30562150
Indian J Dermatol. 2009 Jul;54(3):201-5
pubmed: 20161847
Dermatol Surg. 2006 May;32(5):601-10
pubmed: 16706753
Plast Reconstr Surg. 2015 Jan;135(1):277-85
pubmed: 25285683
Ann Surg Oncol. 2018 Aug;25(8):2235-2240
pubmed: 29786124